Welcome to the Samaritan Center for Medical Research & Clinical Trials
|
||||||||||||||||||||||||||||||||
Dr. Chakerian is founder of, and Principal Investigator for the Samaritan Center for Medical Research (SCMR), an organization formed for the purpose of conducting clinical trials for the drug and medical device industries. If you're interested in participating in clinical trials being conducted by SCMR or other organizations, or would like to know more about what's going on with the latest drug or device developments, please visit our clinical trials site at the link provided below. Maia U. Chakerian - Principal Investigator:
|
 |
Clinical Trials Currently Recruiting
- Low back pain
- Fibromyalgia
- Arthritis pain - To see if you qualify please visit www.arthritisheartstudy.com and answer a few screening questions.
- Osteoarthritis of hip or knee, please visit http://oapainstudy.com to answer a few questions and see if you qualify.
- Breakthrough pain (cancer and noncancer)
- Prevention of blood clots in atrial fibrillation
- Long-term cardiovascular safety with NSAIDs
- Safety study with rituximab
Descriptions of Individual Studies
Indications |
Purpose |
Eligibility |
| Osteoarthritis or Rheumatoid arthritis with cardiovascular disease. | To assess the effect of an anti-inflammatory drug on cardiovascular events, gastrointestinal events, renal events and symptomatic benefits. | Male and female, 18 years and above. With established or at high risk of coronary vascular disease and arthritis of at least 6 month duration. |
| Chronic pain secondary to Osteoarthritis of the Knee/Hip. | To assess the safety and efficacy of an experimental analgesic agent. | Male and female, ages 40 to 70 years, with history of osteoarthritis of knee of hip. |
| Moderate to severe chronic low back pain. | To assess the efficacy and safety of an experimental drug with controlled adjustment of dose. | Male and female patients, 18 years and above with a diagnosis of low back pain on non-malignant origin. |
| Non valvular atrial fibrillation | To compare the efficacy and safety of an experimental drug for the prevention of stroke and non central nervous system systemic embolism. | Male and female patients, 18 years and above, with non-valvular atrial fibrillation documented by ECG on at least 2 occasions. |
| Breakthrough pain in cancer patients. | To evaluate the long term safety and effectiveness of an experimental drug. | Open to make and female patients, 17 years or older with cancer related pain. |
| Breakthrough pain in Opioid-tolerant patients with chronic pain | To evaluate the efficacy and safety of an opioid drug compared with immediate release oxycodone. | Male and female patients 18 to 80 years of age with chronic pain of at least 3 months duration. |
| Breakthrough cancer pain | To evaluate the safety and efficacy of an opioid drug. | Male and female patients ages 18 and above, who experience on average 1 to 4 episodes of breakthrough pain per day. |
| Moderate to severe chronic pain | To evaluate the long term efficacy and safety of an experimental drug. | Open to male and non-pregnant, non-lactating female subjects, 18 and over. |
Research Experience
- Cancer pain
- Non-cancer pain
- Implantable devices
- Neuropathic pain
- Migraine headaches
- Post-operative pain
- Low back pain
- Osteoarthritis pain
- Fibromyalgia
Sponsors, Clinical Research Organizations and IRB's
Sponsors
- Elan
- Allergan
- Pharmacia
- Pfizer
- AstraZeneca
- Faulding
- Purdue Pharma
- Cephalon
- Johnson & Johnson
- Abbott
- Wyeth
- Insys
- Neuromed
- GlaxoSmithKline
- Medgenex
CRO’s
- Covance
- Clinimetrics
- Icon
- INC
- Kendle
- I3
- Paragon
- PPD
- Quintiles
IRB's
- Biomed
- Western IRB
- Sterling
- Coast
Sub Investigators Specialties
- Orthopedics
- Cardiac surgery
- Podiatry
- Cardiology
- Rheumatology
- Pulmonology
- Neurosurgery
- Vascular surgery
Clinical Research Coordinator
Jack Taw - jtaw@samaritan-research.com
Contact Phone:
408-356-0503
Research Assistant:
Lubna Salmaan, M.B.B.S. lubna@samaritan-research.com
About Our Research Main Office
The main office of Samaritan Center for Medical Research occupies 2000 sq. ft. in a medical arts building adjacent to Good Samaritan Hospital in San Jose, California. The office is 5 miles from downtown San Jose and the San Jose International Airport, and is conveniently located along public transportation routes.
Equipment & Services:
- Centrifuge
- Phlebotomy station
- CLIA certificate
- EKG
- Freezer to -20˚C
- Double-locked drug storage cabinets
- Secure records, some stored onsite, others archived and readily available
- Analog line
- DSL internet connection
- Electronic medical records
- Separate workspace for study monitors is available, with telephone, printer, copier, and fax
Hospital Facility
SCMR provides skilled medical staffing and leading edge hospital facilities through its arrangement with Good Samaritan Hospital in San Jose, California. Hospital Facilities10 beds are available for the use of SCMR at Good Samaritan Hospital for inpatient or outpatient use.
Equipment & Services:
Phlebotomy, including the ability to draw samples for pharmacokinetic studies Full, certified clinical laboratory, including microbiology CT scan, MRI scan, ultrasound, DEXA scan, EKG, EEG, continuous cardiac monitoring, spirometry, available Pharmacy Freezer to -20˚C and to -70˚C Nursing staff available as needed Hospital meals provided as needed Separate workspace with dedicated phone and data lines (for study monitors).